Board of Directors


Mr. Gary Schweikhardt, a Seattle area biotechnology entrepreneur and executive with more than 20 years of hands-on experience in establishing and managing high tech organizations including those focused on epigenetic technologies.

Dr. Robert Day, former president of Fred Hutchinson Cancer Research Center, biotechnology entrepreneur and clinical expert.

Dr. Bruce L.A Carter, former president and CEO of ZymoGenetics, Inc., a biotechnology entrepreneur and drug development expert.

Dr. Sledziewski represents Metheor Therapeutics Corp management on the Board.